Lastly, the expression of the immune checkpoint receptor programmed cell death-1 protein (PD1) was also analyzed on these NK cells, and when we compare its expression between healthy control and BC samples (total or receptor-positive patients), there was not significative difference between both groups (Figures 6C, S8B). This evidence concerns the gene PDCD1 and breast cancer.